cefotaxime and Respiratory-Distress-Syndrome

Group A streptococcus (GAS) is a major bacterial pathogen affecting children globally. Approximately 15% of school-age children experience a symptomatic episode of GAS culture-positive pharyngitis each year. Although the incidence of invasive GAS disease under these circumstances is low (0.5%-2%), an increasing number of invasive GAS cases have been reported over the last 2 decades. This report describes a 7-year-old boy who, after being treated for GAS pharyngitis, developed a fatal streptococcal toxic shock syndrome.

Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefotaxime; Child; Clindamycin; Drug Therapy, Combination; Emergencies; Fatal Outcome; Fluid Therapy; Hemorrhage; Humans; Hypotension; Intubation, Intratracheal; Male; Pharyngitis; Respiration, Artificial; Respiratory Distress Syndrome; Shock, Septic; Streptococcal Infections; Streptococcus pyogenes